Analysts See Multiple Growth Levers for CVS in 2026 – CVS Health (NYSE:CVS)

CVS Health Corp. (NYSE:CVS) reported revenue of $105.69 billion, beating Tuesday’s consensus of $103.59 billion. Adjusted earnings of $1.09 per share also beat analyst expectations of 99 cents, down from $1.19 last year. CVS Health reaffirmed its fiscal 2026 adjusted earnings forecast of $7.00-$7.20 per share, compared to the Street consensus of $7.17. The company […]

CVS Caremark Replaces Amgen and Eli Lilly’s Branded Drugs, Expands Biosimilar Strategy for Weak Bone Conditions – CVS Health (NYSE:CVS)

CVS Health Inc. (NYSE:CVS) said Thursday it is taking additional steps to reduce prescription drug costs by expanding access to biosimilar medications, and announced new formulation changes that will take effect in 2026. Beginning April 1, 2026, CVS Caremark will add the osteoporosis biosimilars Ospomyv and Stoboclo, along with the generic teriparatide products Bonsity and […]

Are markets open at Christmas? Here’s What’s Open and What’s Closed on December 25 – Costco Wholesale (NASDAQ:COST), CVS Health (NYSE:CVS)

As families across the country gather to celebrate Christmas on Thursday, December 25, Americans should be prepared for a mix of closures and adjusted timings. What is closed at Christmas? Most federal and financial institutions will suspend their activities on Thursday. Banks, post offices and the stock market (NYSE and Nasdaq) are all closed. Major […]

Trump’s Drug Prize Order is hiding PBMS: CVS, CIGNA, UNH in Focus as experts emphasize ‘Racket,’ Price determination – CVS Health (NYSE: CVS), Cigna Group (NYSE: CI)

After Donald Trump Last week, the experts signed an Executive Order who lowered the prices for medicines, experts emphasized how pharmacy benefit managers (PBMs) can be struck the most difficult, despite pharmaceutical companies that are confronted with the potential of compressed margins in the midst of poor price power. What happened: According to Thomas Shipp, […]